HRP20050584A2 - Peptidi koji su usmjereni na tumor i endotelne stanice, mješavine i njihove upotrebe - Google Patents

Peptidi koji su usmjereni na tumor i endotelne stanice, mješavine i njihove upotrebe Download PDF

Info

Publication number
HRP20050584A2
HRP20050584A2 HR20050584A HRP20050584A HRP20050584A2 HR P20050584 A2 HRP20050584 A2 HR P20050584A2 HR 20050584 A HR20050584 A HR 20050584A HR P20050584 A HRP20050584 A HR P20050584A HR P20050584 A2 HRP20050584 A2 HR P20050584A2
Authority
HR
Croatia
Prior art keywords
compound
substituted
hydrogen
acyl
alkyl
Prior art date
Application number
HR20050584A
Other languages
English (en)
Croatian (hr)
Inventor
L. Allan Amy
Hyung Yoon Won
L. Gladstone Patricia
J. Ternansky Robert
Parry Graham
Donate Fernando
Mazar Andrew
Original Assignee
Attenuon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Attenuon filed Critical Attenuon
Publication of HRP20050584A2 publication Critical patent/HRP20050584A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HR20050584A 2002-11-25 2003-11-25 Peptidi koji su usmjereni na tumor i endotelne stanice, mješavine i njihove upotrebe HRP20050584A2 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42917402P 2002-11-25 2002-11-25
US47553903P 2003-06-02 2003-06-02
PCT/US2003/037895 WO2004063213A2 (en) 2002-11-25 2003-11-25 Peptides which target tumor and endothelial cells, compositions and uses thereof

Publications (1)

Publication Number Publication Date
HRP20050584A2 true HRP20050584A2 (hr) 2006-04-30

Family

ID=32397181

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20050584A HRP20050584A2 (hr) 2002-11-25 2003-11-25 Peptidi koji su usmjereni na tumor i endotelne stanice, mješavine i njihove upotrebe
HR20050585A HRP20050585A2 (en) 2002-11-25 2003-11-25 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
HR20050585A HRP20050585A2 (en) 2002-11-25 2003-11-25 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof

Country Status (14)

Country Link
US (2) US7517855B2 (enExample)
EP (2) EP1569678A4 (enExample)
JP (2) JP2006514116A (enExample)
KR (2) KR20050096917A (enExample)
AU (2) AU2003298726A1 (enExample)
BR (2) BR0316523A (enExample)
CA (2) CA2507045A1 (enExample)
EA (2) EA200500871A1 (enExample)
HR (2) HRP20050584A2 (enExample)
MX (2) MXPA05005469A (enExample)
NO (2) NO20053111L (enExample)
NZ (2) NZ540363A (enExample)
PL (2) PL377763A1 (enExample)
WO (2) WO2004047771A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004047771A2 (en) * 2002-11-25 2004-06-10 Attenuon, Llc. Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
EP1766405A1 (en) * 2004-05-21 2007-03-28 MDS Inc. doing Business Through Its MDS Pharma Services Division Method of quantifying the cell-binding properties of a medical device
US20060078535A1 (en) * 2004-10-13 2006-04-13 The Regents Of The University Of Michigan Anticancer compounds and methods
JP2008528635A (ja) 2005-02-01 2008-07-31 アテニュオン，エルエルシー Ａｃ−ＰＨＳＣＮ−ＮＨ２の酸付加塩
KR20070100832A (ko) * 2005-02-01 2007-10-11 아테뉴온, 엘엘씨 항혈관신생 ｐｈｓｃｎ 펩티드를 함유하는 조성물
CA2668500C (en) * 2006-11-08 2018-07-31 Chongxi Yu Transdermal delivery systems of peptides and related compounds
AU2016213759B2 (en) * 2006-11-08 2018-03-29 Chongxi Yu Transdermal delivery systems of peptides and related compounds
EP4067370A1 (en) 2009-05-08 2022-10-05 Chongxi Yu High penetration prodrug compositions of peptides and peptide related compounds
KR101228668B1 (ko) 2010-09-17 2013-01-31 가톨릭대학교 산학협력단 혈관신생 억제 활성을 갖는 펩타이드 및 이의 용도
GB2510488B (en) 2011-06-23 2020-04-08 Univ Texas Identifying peptides at the single molecule level
US11435358B2 (en) 2011-06-23 2022-09-06 Board Of Regents, The University Of Texas System Single molecule peptide sequencing
CN102417540A (zh) * 2011-11-21 2012-04-18 中国药科大学 一种聚乙二醇修饰的整合素阻断剂hm-3及其应用
EP2846847B1 (en) * 2012-05-11 2020-03-25 C.P. Medical Corporation Biocompatible hydrogel treatments for retinal detachment
CA2875369C (en) 2012-06-04 2017-11-21 Suncor Energy Inc. Formulations containing paraffinic oil and anti-settling agent
EP2967056B1 (en) 2013-03-15 2018-02-21 Suncor Energy Inc. Herbicidal compositions
JP5970439B2 (ja) * 2013-09-20 2016-08-17 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
EP3543703A1 (en) * 2014-09-15 2019-09-25 Board of Regents, The University of Texas System Improved single molecule peptide sequencing
EP3821010A4 (en) 2018-07-12 2022-04-20 Board of Regents, The University of Texas System Molecular neighborhood detection by oligonucleotides
JP7588289B2 (ja) 2019-02-15 2024-11-22 ニュートリエン・エージー・ソリューションズ・（カナダ）・インコーポレイテッド 植物の健康を増進するプロトポルフィリンｉｘ誘導体及びその使用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
EP0051682B1 (en) * 1980-05-13 1984-09-05 Mitsubishi Kasei Corporation Cysteine derivatives and process for their preparation
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
US4394519A (en) * 1982-01-19 1983-07-19 Research Corporation Amino acid blocking agents
GB8504253D0 (en) * 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5091176A (en) * 1988-11-02 1992-02-25 W. R. Grace & Co.-Conn. Polymer-modified peptide drugs having enhanced biological and pharmacological activities
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5229366A (en) * 1990-10-23 1993-07-20 Fuji Photo Film Co., Ltd. Peptide-containing polyethylene glycol derivatives and application thereof
US5149801A (en) * 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US5639725A (en) * 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
ZA962077B (en) * 1995-03-14 1997-03-26 Siemens Ag Ultrasonic atomizer device with removable precision dosating unit
JP3142577B2 (ja) * 1995-03-14 2001-03-07 シーメンス アクチエンゲゼルシヤフト 着脱自在な精密計量供給ユニット
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
EP0927045B1 (en) * 1996-09-10 2005-12-14 The Burnham Institute Tumor homing molecules, conjugates derived therefrom, and methods of using same
US6331409B1 (en) * 1996-11-21 2001-12-18 The Regents Of The University Of Michigan Methods and compositions for wound healing
US6001965A (en) * 1996-11-21 1999-12-14 The Regents Of The University Of Michigan Anticancer compounds and methods
US6025150A (en) * 1996-11-21 2000-02-15 The Regents Of The University Of Michigan Methods and compositions for wound healing
WO1998030538A1 (en) * 1997-01-14 1998-07-16 Kaneka Corporation Process for producing cysteine derivatives
US5994309A (en) * 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
DE69839844D1 (de) * 1997-09-10 2008-09-18 Burnham Inst Verfahren zur auffindung von zielsuchenden verbindungen spezifisch für angiogenese vaskulatur
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
WO2000009537A2 (en) * 1998-08-14 2000-02-24 Administrators Of The Tulane Educational Fund Compounds having growth hormone releasing activity
DE60221115T2 (de) 2001-01-18 2008-03-13 The Regents Of The University Of Michigan, Ann Arbor Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
WO2004047771A2 (en) * 2002-11-25 2004-06-10 Attenuon, Llc. Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof

Also Published As

Publication number Publication date
NO20053111D0 (no) 2005-06-24
NZ540889A (en) 2008-09-26
NZ540363A (en) 2007-11-30
PL377701A1 (pl) 2006-02-06
NO20053112L (no) 2005-08-05
WO2004063213A3 (en) 2005-03-03
EP1594521A2 (en) 2005-11-16
NO20053111L (no) 2005-08-24
HRP20050585A2 (en) 2006-02-28
EP1594521A4 (en) 2008-01-09
US20050020810A1 (en) 2005-01-27
EP1569678A4 (en) 2008-01-02
MXPA05005545A (es) 2005-10-18
WO2004047771A3 (en) 2005-09-15
US20040162239A1 (en) 2004-08-19
US7517855B2 (en) 2009-04-14
PL377763A1 (pl) 2006-02-20
KR20050097494A (ko) 2005-10-07
KR20050096917A (ko) 2005-10-06
BR0316550A (pt) 2005-10-04
AU2003298726A1 (en) 2004-08-10
MXPA05005469A (es) 2005-09-08
EA200500871A1 (ru) 2006-04-28
WO2004063213A2 (en) 2004-07-29
JP2006514116A (ja) 2006-04-27
BR0316523A (pt) 2005-10-18
JP2006515866A (ja) 2006-06-08
NO20053112D0 (no) 2005-06-24
CA2507045A1 (en) 2004-06-10
AU2003297609A1 (en) 2004-06-18
EA200500870A1 (ru) 2006-04-28
EP1569678A2 (en) 2005-09-07
WO2004047771A2 (en) 2004-06-10
CA2506813A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
JP6838118B2 (ja) Ｐｓｍａ結合性リガンド−リンカー結合体及び使用方法
HRP20050584A2 (hr) Peptidi koji su usmjereni na tumor i endotelne stanice, mješavine i njihove upotrebe
KR102791088B1 (ko) EphA2에 특이적인 바이사이클릭 펩티드 리간드
EP3555627B1 (en) Fibroblast activation protein (fap)-targeted imaging and therapy
JP2021130672A (ja) Ｍｔ１−ｍｍｐに特異的な二環性ペプチドリガンド
CN107624115B (zh) 肉毒神经毒素特异性捕获剂、组合物、使用方法和制造方法
MXPA06001090A (es) Agentes de imagenologia de peptido biciclico.
NO333066B1 (no) Peptidbaserte forbindelser, farmasoytisk sammensetning omfattende en slik forbindelse, anvendelse av en slik forbindelse samt fremgangsmate for a danne bilder av et menneske eller en annen dyrekropp.
JP2023099047A (ja) 炭酸脱水酵素陽性がんを標的とするｆｂｓａ系治療および放射性造影複合体
US10857234B2 (en) Carbonic anhydrase IX inhibitor conjugates and uses thereof
US20050232924A1 (en) Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
CA3235116A1 (en) Epha2 bicyclic peptide ligand and conjugate thereof
ZA200504222B (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
Anselmi Peptidomimetic ligands for tuning integrin-mediated signalling: rational design, synthesis and theranostic applications
HK40016594A (en) Fibroblast activation protein (fap)-targeted imaging and therapy
HK40016594B (en) Fibroblast activation protein (fap)-targeted imaging and therapy
HK40031566A (en) Fbsa-based therapeutic and radioimaging conjugates targeting carbonic anhydrase positive cancers
HK1088239A (en) Peptides which target tumor and endothelial cells, compositions and uses thereof

Legal Events

Date Code Title Description
ODRP Renewal fee for the maintenance of a patent

Payment date: 20051125

Year of fee payment: 3

A1OB Publication of a patent application
OBST Application withdrawn